Boston Scientific forecasts Q4 2026 net sales decline of 1%-3%

Bitget2026/10/28 10:38

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Boston Scientific forecasts full-year 2026 adjusted earnings of $3.16-$3.18 per share.
Annual reported sales growth is projected at approximately 4.25%; organic growth is expected at approximately 3.75%.
Fourth-quarter 2026 reported sales are expected to decline 1%-3% year over year, matching the organic sales outlook.
Adjusted earnings are forecast at $0.77-$0.79 per share for the quarter.
Third-quarter 2026 sales rose 1.5% to $5.14 billion, with several businesses affected by a cyber incident.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Boston Scientific forecasts Q4 2026 net sales decline of 1%-3%

You may also like

Crypto prices